PINK:CUBT

Curative Biotechnology, Inc. Stock Insider Trading

Pink Sheets > Healthcare > Biotechnology

$0.0164

+0.0007 (+4.46%)

At Close: Jun 28, 2024

Curative Biotechnology, Inc. Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 CUBT shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About Curative Biotechnology, Inc.

Curative Biotechnology, Inc. operates as a development-stage biomedical company. The company develops pipeline focusing on therapeutic areas, such as infectious diseases, oncology, and degenerative eye disease. Its pipeline candidates include IMT504, a novel immune therapy to treat rabies and an adjuvant for vaccines; CUBT906, a fully humanized CD56 monoclonal antibody carrying a pyrrolobenzodiazepine dimer directly to the tumor site to kill the ... CUBT Profile

Golden Star

Ticker	Date	Change	Price
FFIV	Jun 26	1.75%	$169.26
VIGI	Jun 26	0.694%	$80.72
EHC	Jun 25	1.08%	$84.87
SNAP	Jun 24	6.00%	$15.67
EVBG	Jun 21	0.662%	$34.76
DDOG	Jun 21	10.31%	$117.57
SRE	Jun 20	0.768%	$75.48
PEG	Jun 20	0.163%	$73.58
DOC	Jun 20	1.14%	$19.38
EPD	Jun 18	2.40%	$28.30

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In